Can a simple drug cut blood loss in extreme pelvic surgery?
NCT ID NCT03128866
First seen Nov 01, 2025 · Last updated Apr 28, 2026 · Updated 26 times
Summary
This early-stage trial tests whether tranexamic acid (TXA) can reduce blood loss in patients with pelvic tumors undergoing hemipelvectomy, a surgery that removes part of the pelvis. About 80 adults and children will receive TXA or a placebo during surgery. The goal is to see if TXA helps stabilize blood clots and lower the need for blood transfusions.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PELVIC MASS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
M D Anderson Cancer Center
Houston, Texas, 77030, United States
Conditions
Explore the condition pages connected to this study.